Trust Point Inc. acquired a new stake in shares of Maximus, Inc. (NYSE:MMS – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 5,124 shares of the health services provider’s stock, valued at approximately $430,000.
Other large investors have also recently added to or reduced their stakes in the company. Legato Capital Management LLC lifted its position in Maximus by 134.1% during the fourth quarter. Legato Capital Management LLC now owns 23,521 shares of the health services provider’s stock worth $1,972,000 after buying an additional 13,474 shares during the period. Graham Capital Management L.P. purchased a new position in Maximus during the third quarter worth about $2,709,000. SG Capital Management LLC purchased a new position in Maximus during the third quarter worth about $5,951,000. SG Americas Securities LLC purchased a new position in Maximus during the third quarter worth about $2,262,000. Finally, QRG Capital Management Inc. purchased a new position in Maximus during the third quarter worth about $471,000. 97.21% of the stock is currently owned by hedge funds and other institutional investors.
Maximus Stock Performance
Maximus stock opened at $81.07 on Friday. The stock’s 50-day moving average is $82.74 and its 200-day moving average is $80.78. The company has a market cap of $4.95 billion, a price-to-earnings ratio of 26.84 and a beta of 0.72. The company has a debt-to-equity ratio of 0.71, a current ratio of 1.69 and a quick ratio of 1.69. Maximus, Inc. has a 12 month low of $72.39 and a 12 month high of $89.69.
Maximus Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Thursday, February 29th. Stockholders of record on Thursday, February 15th were paid a $0.30 dividend. The ex-dividend date of this dividend was Wednesday, February 14th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.48%. Maximus’s dividend payout ratio (DPR) is currently 39.74%.
Insider Activity
In other news, CFO David Mutryn sold 8,000 shares of the stock in a transaction dated Friday, February 16th. The stock was sold at an average price of $83.95, for a total value of $671,600.00. Following the completion of the sale, the chief financial officer now owns 5,124 shares in the company, valued at $430,159.80. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Insiders own 1.40% of the company’s stock.
Analyst Upgrades and Downgrades
A number of equities analysts have recently commented on MMS shares. StockNews.com upgraded Maximus from a “hold” rating to a “buy” rating in a report on Thursday, February 8th. Raymond James downgraded Maximus from an “outperform” rating to a “market perform” rating in a report on Wednesday, January 3rd.
Check Out Our Latest Analysis on MMS
About Maximus
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Read More
- Five stocks we like better than Maximus
- Upcoming IPO Stock Lockup Period, Explained
- Beazer Homes USA is an Overlooked Opportunity in Housing
- What Investors Need to Know About Upcoming IPOs
- 5 Stocks in the Current Bull Market with Upside to Come
- What Are Growth Stocks and Investing in Them
- 5 High Short Interest Stocks Getting Squeezed With Upside To Go
Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMS – Free Report).
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.